May 15, 2026 · Form 4 insider transaction
Maunsell Farris Maryanne bought 2,220 shares of Haemonetics Corporation, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.; Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.; This number includes unvested RSUs previously reported.